Pemphigus Treatment in Japan

Dermatologic Clinics

Volumn 29, Issue 4, 2011, Pages 685-686

  Tanikawa, Akiko ^a   Amagai, Masayuki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ELISA; Epidemiology; Japan; PDAI; Pemphigus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DESMOGLEIN 1; DESMOGLEIN 3; IMMUNOGLOBULIN; METHOTREXATE; PREDNISOLONE;

BULLOUS SKIN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMATOUS PEMPHIGUS; HUMAN; INCIDENCE; JAPAN; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VEGETANS; PEMPHIGUS VULGARIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEX RATIO;

ADRENAL CORTEX HORMONES; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; JAPAN; MALE; PEMPHIGUS; PRACTICE GUIDELINES AS TOPIC;

EID: 80052880877     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.07.004     Document Type: Review

References (7)

1. Amagai M. Pemphigus. Dermatology 2008, 417-429. Mosby, Spain. 2nd edition. J.L. Bolognia, J.L. Jorizzo, R.P. Rapini (Eds.).
2. Immamura S. A form for the diagnosis of pemphigus. Annual Report of the Intractable Skin Disease Study Group 1991, Ministry of Welfare and Health of Japan, Japan, p. 12 [in Japanese].
3. Committee for Guidelines for the Management of Pemphigus Disease, Amagai M., Tanikawa A., et al. Guidelines for the management of Pemphigus. Jpn J Dermatol 2010, 120(7):1443-1460.
4. Murrell D.F., Dick S., Ahmed A.R., et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008, 58:1043-1046.
5. Amagai M., Ikeda S., Shimizu H., et al. A randomized double-blind trial of intravenous immunoglobulin for pemphigus. J Am Acad Dermatol 2009, 60:595-603.
6. Tanikawa A. Managing pemphigus with PDAI (Pemphigus Disease Area Index), a new measure for disease activity in pemphigus. Clin Dermatol 2011, 65:110-113.
7. Faurschou A., Gniadecki R. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris. Int J Dermatol 2008, 47:292-294.